Casey Edwards
Family · Middleburg, FLNPI 1245587393
Payments from drug & device makers
Across 285 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$626
- AstraZeneca$496
- Lilly USA, LLC$308
- Pfizer$255
- Amgen$216
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,015100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,072 |
| Novo Nordisk | 34 | $626 |
| AstraZeneca | 31 | $496 |
| Lilly USA, LLC | 20 | $308 |
| Pfizer | 13 | $255 |
| Amgen | 14 | $216 |
| Recor Medical Inc | 1 | $162 |
| Boehringer Ingelheim | 11 | $161 |
| Bayer | 7 | $148 |
| Sanofi-aventis U.S. LLC | 8 | $143 |
| Amarin Pharma, Inc. | 9 | $141 |
| Exact Sciences | 7 | $118 |
| GSK | 6 | $99 |
| Astellas Pharma US Inc | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Abbott | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Eisai Inc. | 4 | $61 |
| Merck | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Novartis | 3 | $47 |
| Dexcom, Inc. | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| IBSA Pharma Inc. | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Almatica Pharma LLC | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Noven Therapeutics, LLC | 1 | $25 |
| Clarus Therapeutics Inc. | 2 | $25 |
| Grifols USA, LLC | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Pear Therapeutics (US), Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Axonics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,015 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 11 | $76,120 |
| OzempicSemaglutide | 40 | $42,468 |
| MounjaroTirzepatide | 27 | $36,079 |
| EliquisApixaban | 28 | $34,085 |
| Invega SustennaPaliperidone Palmitate | 12 | $26,723 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $21,928 |
| JardianceEmpagliflozin | 14 | $19,199 |
| LinzessLinaclotide | 14 | $13,996 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $12,115 |
| BelsomraSuvorexant | 22 | $9,627 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $9,391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $3,389 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $2,786 |
| Omeprazole | 72 | $1,632 |
| Gabapentin | 103 | $1,622 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $626 | $42,46840 claims |
| Lilly USA, LLCMounjaro | $308 | $36,07927 claims |
| PfizerEliquis | $255 | $34,08528 claims |
| GSKTrelegy Ellipta | $99 | $21,92835 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $496 | $21,50645 claims |
| Boehringer IngelheimJardiance | $161 | $19,19914 claims |
| AbbVieLinzess | $1,072 | $13,99614 claims |
| MerckBelsomra | $60 | $9,62722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Middleburg
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.